eso-t01
eso-t01: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: WORK Medical Technology Group LTD (WOK)
Development Pipeline (1)
| Company | Phase |
|---|---|
| WORK Medical Technology Group LTD (WOK) | Early Phase 1 |
Clinical Trials (1)
A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
Frequently asked questions
Who is developing eso-t01?
eso-t01 is being developed by WORK Medical Technology Group LTD.
How many clinical trials involve eso-t01?
BioSniper tracks 1 clinical trial involving eso-t01.
Analyze WORK Medical Technology Group LTD & eso-t01 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company